Treatment of cardiogenic shock.
D002301:Cardiac Glycosides / Q000627:therapeutic use; D002395:Catecholamines / Q000627:therapeutic use; D004630:Emergencies; D006439:Hemodynamics; D006801:Humans; D009203:Myocardial Infarction / Q000150:complications* / Q000628:therapy; D012769:Shock / Q000209:etiology / Q000628:therapy*; D013565:Sympatholytics / Q000627:therapeutic use; D013566:Sympathomimetics / Q000627:therapeutic use
D002301:Cardiac Glycosides; D002395:Catecholamines; D013565:Sympatholytics; D013566:Sympathomimetics